BME100 s2015:Group12 12pmL1: Difference between revisions
Line 60: | Line 60: | ||
*Consent of the individuals must be acquired, and all information regarding the experiment will be open to disclosure. | *Consent of the individuals must be acquired, and all information regarding the experiment will be open to disclosure. | ||
*Medical history of selected individuals required (the team does not want to potentially give a harmfull or fatal dose of lipopolysacchiride, if the case presents itself.) | *Medical history of selected individuals required (the team does not want to potentially give a harmfull or fatal dose of lipopolysacchiride, if the case presents itself.) | ||
*Particularly interested in individuals who have active levels of inflammation (the data collected would be relevant to the study and is the team's focus.) | *Particularly interested in individuals who have active levels of inflammation (the data collected would be more relevant to the study and is the team's focus.) | ||
*Less keen on healthy individuals whose inflammation levels are more passive or even dormant (subjects may be placed into control group to increase data accuracy.) | *Less keen on healthy individuals whose inflammation levels are more passive or even dormant (subjects may be placed into control group to increase data accuracy.) | ||
*Actual process of recruitment is through more emphasis on speaking to them directly in person, telephone calls, newspaper and magazine advertisements regarding the study, radio advertisements and pamphlets going through the mail. Less emphasis on internet or email advertisements (potential subjects are less likely to use the Internet or email). | *Actual process of recruitment is through more emphasis on speaking to them directly in person, telephone calls, newspaper and magazine advertisements regarding the study, radio advertisements and pamphlets going through the mail. Less emphasis on internet or email advertisements (potential subjects are less likely to use the Internet or email). |
Revision as of 18:44, 24 January 2015
BME 100 Spring 2015 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
OUR TEAMLAB 1 WRITE-UPWARNING: All material presented here is highly suspectible to change by the team's authors. Final draft will be complete by Tuesday, 11:59 P.M. Independent and Dependent VariablesIndependent Variable: Lipopolysacchride (LPS) would be the variable the research team can alter, because according to the ELISA data analysis for 10 mg LPS, the levels of inflammotin in the blood sample analyzed are affected by a determined amount of the drug. The team will be able to deduce how inflammotin levels interact with a certain dosage of LPS by manipulating this variable. Dependent Variable: Inflammotin is the protein responsible for inflammation and is the central part of the experiment the team will conduct. This variable will fluctuate based on the dosage of LPS the research team will administrator to the test groups. Experimental DesignGroups
Age Age limit is between 60 to 70 years of age. The research team believes this is the prime demographic of elderly individuals whose personal health is adequate. These individuals are less likely to succumb to biological factors such as aging, cell decay, organ failure, and other factors which may apply, often from 71 years of age and older.
4 subjects to each group, totaling 5 groups.
Subject Selection
Sources of Error and Bias
|